10 principais sutrobio.com concorrentes

gossamerbio.com

Protect Yourself from Job Offer Scams Job scams pretending to be reputable companies are on the rise. When considering opportunities at Gossamer Bio, keep these tips in mind: How to Verify Legitimate Offers Common Scam Signs Notice to Search Firms/Third-Party Recruitment Agencies (Recruiters) The Human Resources team manages the recruitment and employment process for Gossamer […]

celldex.com

Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.

molecularpartners.com

Explore Molecular Partners' innovative DARPin platform and its diverse therapeutic candidates targeting oncology and other diseases.

akerotx.com

Our flagship EFX program is designed to be a differentiated, potentially best-in-class treatment for metabolic dysfunction-associated steatohepatitis (MASH).

orumrx.com

Orum to receive a $15 million upfront payment and up to $310 million in potential option fees and milestone payments per target plus tiered royalties   BOSTON, USA & DAEJEON, South Korea, July 16, 2024 – Orum Therapeutics (“Orum” or the “Company”), a clinical-stage private bio

komabiotech.co.kr

고마바이오텍은 Eurofins Discovery 신약개발 분석서비스, 단백질, 항체, 바이러스, 세포주 제작서비스, Luminex Multiplex, 유세포분석기, Tocris Inhibitor, FBS, PBMC, 세포분석 assay kit등 다양한 연구분석 솔루션을 제공합니다.

oligotherapeutics.org

Date Effective: November 10, 2022GeneralThis website (the "Site") is owned and operated by Oligonucleotide Therapeutics Society (“COMPANY” "we" or "us"). By using the Site, you agree to be bound by these Terms of Service and to use the Site in accordance with these Terms

picardlab.org

Picard Lab - Home

allencell.org

Allen Institute for Cell Science - CellScapes: Uncovering the design principles of multicellular programs essential for life